Join us for an insightful and practical event designed for those in the Med-tech and Life Sciences sector looking to expand their operations into the world’s second-largest economy. This event will equip you with the essential knowledge, strategies, and cultural understanding needed to navigate the complexities of the Chinese market successfully.
During the event, delegates can expect to be provided with firsthand knowledge and insights through a series of focused presentations, an industry case study, and a lively panel discussion. The event will conclude with a dedicated networking session, allowing you to build valuable connections.
AGENDA
4pm Arrival & Registration
4:30pm Welcome Introduction
4:45pm Focused Presentations
- Understanding the Chinese Business Mind/ Culture (Lily Lin – Co-Founder and CEO of Excellence first Enterprise Consultancy)
- Legal and IP issues (James Fry – Mills & Reeve)
- Case Study: Medical product partnerships in China (Professor Keith Jackson)
5:15pm Q&A Panel Discussion
6pm Networking
7pm Depart
Speakers
Lily Lin – Co-founder and CEO of Excellence First Enterprise Consultancy (EFEC)
Lily Lin – Co-founder and CEO of Excellence First Enterprise Consultancy (EFEC), a UK–China advisory firm established in 2006 to build strategic partnerships across business, innovation and culture. Her work includes contributing to cross-ecosystem initiatives such as the Lingang–Cambridge Network and partnering with Medilink Midlands to support organisations engaging with China. She is currently leading the development of two new EFEC initiatives planned for rollout in 2026 to mark the organisation’s 20th anniversary: the EFEC UK–China Life Sciences Innovation Hub, which focuses on strengthening trust, alignment and governance between leaders of like-minded innovation ecosystems in both countries; and CognateUK, an evidence-led talent capability initiative exploring upstream development pathways for globally minded professionals.
James Fry – Partner and Head of Life Sciences, Mills & Reeve
James leads our full-service life sciences practice, and advises on IP and IP licensing, strategic contracting and cross-border transactions. He has deep expertise in licensing and partnering, research collaborations, supply chains and the development and distribution of life sciences products, including medical devices and pharmaceuticals. James has notable experience working on deals involving life sciences companies in China, particularly in research collaborations and licensing, and has advised on a number of high profile in-licensing and out-licensing transactions involved Chinese biotechs and pharma companies. His clients include biotech and pharma companies, medical device companies, universities, medical research charities and government bodies.
Professor Keith Jackson
Professor Keith Jackson is a Chartered Engineer and Chartered Director with over forty years of experience in British manufacturing, international trade, and business leadership. He has led multi award-winning MedTech companies, where he designed manufactured and exported innovative healthcare solutions to more than 70 countries, building strong links across Asia and China. As The Master Cutler for 2025–2026, Keith champions international trade, education, and healthcare. A former Non-Executive Director of Medilink, he continues to advise scaling businesses in life sciences on innovation, internationalisation, and leadership. Keith also serves as a Non-Executive Chair and Director for high-growth SMEs, including on an international board in Hong Kong, supporting cross-border collaboration and market expansion for British technology companies.
Panelist
Paul Bowman – Barclays
As the Vertical Head of International for Barclays Business, Paul’s role is to support colleagues and SMEs to explore international trade, by providing insight and education and to confirm that whilst international trade may be complex, it need not be difficult. He has created training and support material for trade and has hosted events and webinars focused upon helping businesses grow through importing and exporting. As well as supporting colleagues and clients, Paul also leans into work with product and propositions, and represents Barclays in discussions with Government, Department of Business & Trade and other external agencies. With over 30 years’ experience within the banking industry, he is a keen ally of those looking to broaden access to the opportunities available through overseas trade and activity.
